Top Markets
Coin of the day
Alimera Sciences, Inc. Alimera Sciences, Inc.

Alimera Sciences, Inc.

ALIM
Pozycja w akcjach #26668
Alimera Sciences, Inc. is a pharmaceutical company focused on developing and... Alimera Sciences, Inc. is a pharmaceutical company focused on developing and commercializing ophthalmic treatments globally, including in the United States. Its primary offering, ILUVIEN, is an intravitreal implant used to manage diabetic macular edema (DME), a severe retinal disease in individuals with diabetes that can lead to profound vision loss and blindness. Additionally, ILUVIEN helps prevent relapses of recurrent non-infectious uveitis affecting the posterior segment of the eye. The company distributes its products directly and through distributors to various healthcare entities such as physician offices, pharmacies, and hospitals. Alimera also maintains a collaboration with EyePoint Pharmaceuticals US, Inc. focused on developing and marketing insert technology. This technology is designed to deliver corticosteroids to the back of the eye for treating and preventing various human eye diseases, including diabetic macular edema. Founded in 2003, Alimera Sciences is headquartered in Alpharetta, Georgia.
Cena akcji
$5.54
Ostatnia synchronizacja: 2024-09-18
Kapitalizacja rynkowa
$38.76M
Zmiana (1 dzień)
0.00%
Zmiana (1 rok)
0.00%
Kraj
US
Handel Alimera Sciences, Inc. (ALIM)

Kategoria

Historia ceny akcji dla Alimera Sciences, Inc. (ALIM)
Najwyższa cena zamknięcia: $5.51 dnia 2024-09-01

Najniższa cena zamknięcia: $164.97 dnia 2010-04-01
Historia cen akcji firmy Alimera Sciences, Inc. od 2010 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2024 46.84%
2023 40.43%
2022 -44.81%
2021 11.99%
2020 -42.79%
2019 -44.64%
2018 -30.34%
2017 18.43%
2016 -59.98%
2015 -50.90%
2014 77.48%
2013 91.17%
2012 25.74%
2011 -87.80%
2010 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
$171.67 -
DE
$162.86 25.18%
DE
$38.00 22.72%
JP
$219.99 32.88%
CH
$21.01 11.96%
IN